Kanlaya Sornwong

Nakhon Phanom, Thailand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Safety and Immunogenicity of an Additional Dose of Thailand Government Pharmaceutical Organization (GPO) Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Administered After Primary Vaccination with HXP-GPOVac or BNT162b2: An Open-Label Phase II Extension Trial in Thai Adults.

Safety and Immunogenicity of an Additional Dose of Thailand Government Pharmaceutical Organization (GPO) Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Administered After Primary Vaccination with HXP-GPOVac or BNT162b2: An Open-Label Phase II Extension Trial in Thai Adults.

Journal: Vaccines

Published: June 25, 2026

Safety and Immunogenicity of a Locally Produced Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Compared with BNT162b2: A Phase II Randomized, Controlled, Double-Blind Noninferiority Trial in Thai Adults.

Safety and Immunogenicity of a Locally Produced Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Compared with BNT162b2: A Phase II Randomized, Controlled, Double-Blind Noninferiority Trial in Thai Adults.

Journal: Vaccines

Published: April 28, 2026

Validity of influenza vaccine effectiveness calculations using a test negative design in Thailand.

Validity of influenza vaccine effectiveness calculations using a test negative design in Thailand.

Journal: American journal of epidemiology

Published: August 13, 2025

Validity of influenza vaccine effectiveness calculations using a test-negative design in Thailand.

Validity of influenza vaccine effectiveness calculations using a test-negative design in Thailand.

Journal: American journal of epidemiology

Published: August 13, 2025

Influenza virus circulation and vaccine effectiveness during June 2021-May 2023 in Thailand.

Influenza virus circulation and vaccine effectiveness during June 2021-May 2023 in Thailand.

Journal: Vaccine: X

Published: October 20, 2023

Safety and immunogenicity of locally produced trivalent inactivated influenza vaccine (Tri Fluvac) in healthy Thai adults aged 18-64 years in Nakhon Phanom: A Phase III double blinded, three-arm, randomized, controlled trial.

Safety and immunogenicity of locally produced trivalent inactivated influenza vaccine (Tri Fluvac) in healthy Thai adults aged 18-64 years in Nakhon Phanom: A Phase III double blinded, three-arm, randomized, controlled trial.

Journal: Vaccine

Published: August 27, 2023

Effect of acute respiratory illness on short-term frailty status of older adults in Nakhon Phanom, Thailand-June 2015 to June 2016: A prospective matched cohort study.

Effect of acute respiratory illness on short-term frailty status of older adults in Nakhon Phanom, Thailand-June 2015 to June 2016: A prospective matched cohort study.

Journal: Influenza and other respiratory viruses

Published: November 15, 2018

Streptococcus suis infection in hospitalized patients, Nakhon Phanom Province, Thailand.

Streptococcus suis infection in hospitalized patients, Nakhon Phanom Province, Thailand.

Journal: Emerging infectious diseases

Published: January 28, 2015

Showing 1-8 of 8

Last Updated: 09/26/2026